PT1161248E - Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras - Google Patents

Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras Download PDF

Info

Publication number
PT1161248E
PT1161248E PT00907851T PT00907851T PT1161248E PT 1161248 E PT1161248 E PT 1161248E PT 00907851 T PT00907851 T PT 00907851T PT 00907851 T PT00907851 T PT 00907851T PT 1161248 E PT1161248 E PT 1161248E
Authority
PT
Portugal
Prior art keywords
acidifying agent
burns
pharmaceutical composition
composition containing
open wound
Prior art date
Application number
PT00907851T
Other languages
English (en)
Inventor
Arthur Tudor Tucker
Nigel Benjamin
Original Assignee
Queen Mary & Westfield College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary & Westfield College filed Critical Queen Mary & Westfield College
Publication of PT1161248E publication Critical patent/PT1161248E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
PT00907851T 1999-03-09 2000-03-09 Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras PT1161248E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9905425.6A GB9905425D0 (en) 1999-03-09 1999-03-09 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
PT1161248E true PT1161248E (pt) 2009-08-05

Family

ID=10849290

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00907851T PT1161248E (pt) 1999-03-09 2000-03-09 Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras

Country Status (11)

Country Link
US (3) US20020090401A1 (pt)
EP (1) EP1161248B1 (pt)
JP (1) JP5084985B2 (pt)
AT (1) ATE430573T1 (pt)
AU (1) AU2931500A (pt)
DE (1) DE60042153D1 (pt)
DK (1) DK1161248T3 (pt)
ES (1) ES2326729T3 (pt)
GB (1) GB9905425D0 (pt)
PT (1) PT1161248E (pt)
WO (1) WO2000053193A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780849B2 (en) 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US7025869B2 (en) * 2001-09-05 2006-04-11 Cyterra Corporation Nitric oxide delivery system
DE602004008927T2 (de) 2003-07-09 2008-06-05 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Verwendung von nitritsalzen zur behandlung von kardiovaskulären erkrankungen
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
CA2576957C (en) 2004-08-18 2013-04-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
DE602006006432D1 (de) * 2005-03-24 2009-06-04 Nolabs Ab Kosmetische behandlung mit stickoxid, vorrichtung zur durchführung dieser behandlung und herstellungsverfahren dafür
US20090214618A1 (en) 2005-05-27 2009-08-27 Schoenfisch Mark H Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
GB0607402D0 (en) 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
CA2730009C (en) * 2007-07-12 2017-08-15 Whipbird Pain Relief Pty Ltd. Topical medicament
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US9278157B2 (en) 2007-08-09 2016-03-08 Insense Limited Nitric oxide-generating skin dressings
WO2009055008A1 (en) * 2007-10-24 2009-04-30 Wharton Innovative Products, Llc Two part lotion for the delivery of nitrite ions to the skin
US8877508B2 (en) 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US10080823B2 (en) 2007-10-30 2018-09-25 Gearbox Llc Substrates for nitric oxide releasing devices
US8980332B2 (en) 2007-10-30 2015-03-17 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
WO2009065142A2 (en) 2007-11-15 2009-05-22 Biomedical Research Foundation Of Northwest Louisiana Use of nitrite salts in chronic ischemia
AU2008345034A1 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
JP5554723B2 (ja) 2008-01-28 2014-07-23 ゲノ エルエルシー 二酸化窒素（ｎｏ２）から一酸化窒素（ｎｏ）への変換
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
US20110104240A1 (en) * 2008-06-24 2011-05-05 Micropharma Limited Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections
US8607785B2 (en) * 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
WO2010147742A2 (en) 2009-06-18 2010-12-23 Theravasc Inc. Use of nitrite salts in treating tissue damage
EP2445508B1 (en) 2009-06-22 2018-11-14 VERO Biotech LLC Nitric oxide therapies
CA2771308C (en) 2009-08-21 2020-01-21 Novan, Inc. Topical gels comprising nitric oxide releasing polysiloxane macromolecules
CA2771389C (en) 2009-08-21 2019-04-09 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
ES2633618T3 (es) 2009-10-14 2017-09-22 Theravasc Inc. Formulaciones farmacéuticas de nitrito y sus usos
US8646445B2 (en) * 2009-11-20 2014-02-11 Geno Llc Nitric oxide delivery system
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
BR112014003414B1 (pt) 2011-08-17 2021-09-21 Board Of Regents, The University Of Texas System Composição e sistema de entrega oral para aumento de níveis fisiológicos e terapêuticos de óxido nítrico
BR112015019802A2 (pt) 2013-02-20 2017-07-18 Theravasc Inc formulações farmacêuticas de nitrito e usos das mesmas
GB201309091D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Dressing system
GB201309092D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Transdermal delivery system
GB201420761D0 (en) 2014-11-21 2015-01-07 Edixomed Ltd And First Water Ltd Dressing system
TWI562038B (en) * 2015-07-08 2016-12-11 Wistron Corp Method of detecting touch position and touch apparatus thereof
GB201520990D0 (en) 2015-11-27 2016-01-13 Edixomed Ltd Dressing system
WO2020227367A1 (en) * 2019-05-06 2020-11-12 Pneuma Nitric Oxide, Llc Nitric oxide compositions and topical uses thereof
EP3980032A1 (en) 2019-06-04 2022-04-13 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
JP2023510661A (ja) 2019-06-04 2023-03-15 サーティー ホールディングス リミテッド 窒素酸化物を生成するための方法及び組成物、並びにそれらの使用
JP2023526583A (ja) 2020-04-23 2023-06-22 サーティー レスピラトリー リミテッド 結核を治療及び抑制するための方法及び組成物
EP4138795A1 (en) 2020-04-23 2023-03-01 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH629100A5 (de) * 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
ATE177642T1 (de) * 1992-06-08 1999-04-15 Pitmy Int Nv Distickstoffmonoxide enthaldendes dermatologisches präparat
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
AU693851B2 (en) * 1994-02-21 1998-07-09 Aberdeen University Acidified nitrite as an antimicrobial agent
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
JP3002772B2 (ja) * 1996-05-15 2000-01-24 マルホ株式会社 貼付剤及びその製造法
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US7404990B2 (en) * 2002-11-14 2008-07-29 Air Products And Chemicals, Inc. Non-thermal process for forming porous low dielectric constant films
US7056840B2 (en) * 2003-09-30 2006-06-06 International Business Machines Corp. Direct photo-patterning of nanoporous organosilicates, and method of use

Also Published As

Publication number Publication date
WO2000053193A1 (en) 2000-09-14
EP1161248B1 (en) 2009-05-06
EP1161248A1 (en) 2001-12-12
US20020090401A1 (en) 2002-07-11
ATE430573T1 (de) 2009-05-15
AU2931500A (en) 2000-09-28
GB9905425D0 (en) 1999-05-05
US20080226751A1 (en) 2008-09-18
ES2326729T3 (es) 2009-10-19
DK1161248T3 (da) 2009-08-31
DE60042153D1 (de) 2009-06-18
JP2002538210A (ja) 2002-11-12
JP5084985B2 (ja) 2012-11-28
US20150004258A1 (en) 2015-01-01

Similar Documents

Publication Publication Date Title
PT1161248E (pt) Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras
ES2275716T3 (es) Composicion farmaceutica de liberacion transdermica.
MXPA02002895A (es) Tratamiento topico de infecciones por estreptococcus.
MY132705A (en) Novel compounds with analgesic effect
SE9701162D0 (sv) New use II
WO2001024763A3 (en) Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
GR1002807B (el) Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
HUP0102337A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek felső légutakba és/vagy fülbe történő beadására szolgáló készítmények előállítására
PT746327E (pt) Nitrito acidificado como um agente antimicrobiano
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
NZ513096A (en) Compositions for treating inflammatory response
MY164077A (en) Compositions and uses of et743 for treating cancer
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
MXPA02009904A (es) Derivados de apomorfina y metodos para su uso.
MX9800945A (es) Uso de griseofulvina para inhibir el crecimiento de canceres.
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
NZ514558A (en) Viral treatment
YU11402A (sh) Nova primena docetaksela za lečenje hepatoma
ATE232390T1 (de) Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs
ATE390124T1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
FR2794976B1 (fr) Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
EP1626731A4 (en) ANTI-INFLAMMATORY MEDICINE PREPARATIONS FOR INFLAMMATORY INFLAMMATION AND THE THERAPY OR PROPHYLAXIS OF GASTRIC TOXICITY
ATE310539T1 (de) Artikel zur wundbehandlung